EUVIMEDEUVIMED entdecken
Fallbericht

Asn384Ser Mutation in Protein C is Associated with Multiple-Site Thrombosis in a Young Heterozygous Male

Junwei Yuan, Shijie Zhou iD, Xi Wu, Fang Li, Zhe Lai, Qiulan Ding, Wenman Wu, Xuefeng Wang, Jing Dai, Xiaobo Hu, Yeling Lu

Thrombosis and Haemostasis · 01.04.2026 · 126 (04) · 418-428

DOI: 10.1055/a-2569-6439 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.04.2026. Verfasst von Junwei Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Protein C, Thrombosis, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: General Program of National Natural Science Foundation of China, Shanghai Natural Science Foundation Program, Young Talent Support Program of College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein C (PC) is an important physiological anticoagulant factor in humans. Activated protein C (APC) is generated from the PC zymogen through proteolytic activation by thrombin. APC inhibits thrombin generation by inactivating activated factors V and VIII via limited proteolysis. In addition to its anticoagulant function, APC also exhibits potent cytoprotective and anti-inflammatory properties. We have identified a young male with multiple-site thrombosis, who carries a heterozygous mutation c.1151A > G,p.Asn384Ser(N384S) in PC. Although this mutation has been previously documented, limited functional research has been conducted to elucidate its pathogenesis. To elucidate the functional alternations of the N384S mutant protein C and delineate the molecular mechanism underlying thrombosis in the patient carrying this mutation. We expressed the recombinant PC-N384S in mammalian cells and characterized its properties in established coagulation and anti-inflammatory assay systems. The expression level of the PC-N384S was reduced to approximately 7% of that observed for PC-WT. The activation of PC-N384S by thrombin or thrombin–thrombomodulin (TM) complex was significantly impaired, although the addition of TM exhibited a slight enhancement in the activation process. In terms of cleaving a chromogenic substrate, the catalytic efficiency reduced to approximately 50% of that observed in the wild type. In addition, in comparison with APC-WT, APC-N384S demonstrated a pronounced decline in amidolytic activity following an extended incubation period at 37°C. APC-N384S exhibited slightly impaired anticoagulant activity in either FVa inhibition assay or plasma-based assay systems. Furthermore, anti-inflammatory activity of APC-N384S was dramatically impaired as determined by evaluating the barrier-protective effect. The Asn384Ser mutation impairs both the anticoagulant and barrier-protective activities of protein C, thereby increasing the thrombosis risk in the heterozygous young male.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein CThrombosisMutationHumansMaleHeterozygoteThrombinBlood CoagulationAdultGenetic Predisposition to DiseaseThrombomodulinRecombinant Proteins

Substanzen

Protein CThrombinThrombomodulinRecombinant Proteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Microbial Metabolism & Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Shanghai Center for Clinical Laboratory, Shanghai, China.

ORCID-Profile: Shijie Zhou

Förderung

  • General Program of National Natural Science Foundation of China
  • Shanghai Natural Science Foundation Program
  • Young Talent Support Program of College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Yuan, J., Zhou, S., Wu, X., Li, F., Lai, Z., Ding, Q., Wu, W., Wang, X., Dai, J., Hu, X., & Lu, Y. (2026). Asn384Ser Mutation in Protein C is Associated with Multiple-Site Thrombosis in a Young Heterozygous Male. Thrombosis and Haemostasis, 126(04), 418-428. https://doi.org/10.1055/a-2569-6439

Vancouver

Yuan J, Zhou S, Wu X, Li F, Lai Z, Ding Q, et al. Asn384Ser Mutation in Protein C is Associated with Multiple-Site Thrombosis in a Young Heterozygous Male. Thrombosis and Haemostasis. 2026;126(04):418-428. doi:10.1055/a-2569-6439

BibTeX
@article{Yuan2026,
  author = {Yuan, Junwei and Zhou, Shijie and Wu, Xi and Li, Fang and Lai, Zhe and Ding, Qiulan and Wu, Wenman and Wang, Xuefeng and Dai, Jing and Hu, Xiaobo and Lu, Yeling},
  title = {Asn384Ser Mutation in Protein C is Associated with Multiple-Site Thrombosis in a Young Heterozygous Male},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {04},
  pages = {418--428},
  doi = {10.1055/a-2569-6439}
}
Kostenlos starten →